FDA harmonization
Executive Summary
Agency has the draft report of the task force on harmonization and is "working to see how to best meld the activities that are suggested in that with FDA's own long-term planning document," Associate Commissioner for Health Affairs Stuart Nightingale tells the Parenteral Drug Association/FDA 1992 Joint Conference on Sept. 21. The report will help FDA set priorities and allocate resources for its harmonization activities, he notes. The agency hopes the report will be publicly available "soon".
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth